Clinical Trials Browser

Phase 2 × Refractory Solid Tumors × Hydralazine × Clear all

NCT00404508 2006-11-28

A Phase II Study of Epigenetic Therapy to Overcome Chemotherapy Resistance in Refractory Solid Tumors

Phase 2 Completed

Other solid neoplasm

Refractory Solid Tumors